Moderna says its Omicron-specific vaccine boosts antibodies in new trial

Those who received a booster shot of the Omicron-targeted vaccine had high antibody levels a month later that were 8-fold higher than their baseline levels, Moderna said. Read More

Read More?

Post is imported from RSS feed, by one of our guest editors. G6 does not edit or moderate the content. G6 is not responsible for your actions. No rights owned by G6. To remove the post, please email us at [email protected]rg

No Comments

Sorry, the comment form is closed at this time.